About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

Indonesian central bank governor: We are optimistic about GDP growth this year and expect it to improve further next year.

2026-06-09

Indonesian central bank governor: We are optimistic about GDP growth this year and expect it to improve further next year.

Other News
2026-06-09

GDS Holdings (GDS.O) shares surged more than 8% in pre-market trading.

GDS Holdings (GDS.O) shares surged more than 8% in pre-market trading.
2026-06-09

Individual Stock News 1. Contron (01912.HK) will see a change of controlling stake, with a takeover offer made at a discount of approximately 34.82%. Trading will resume on June 9. 2. SENASIC (06675.HK) will conduct its IPO from June 9 to June 12,

Individual Stock News 1. Contron (01912.HK) will see a change of controlling stake, with a takeover offer made at a discount of approximately 34.82%. Trading will resume on June 9. 2. SENASIC (06675.HK) will conduct its IPO from June 9 to June 12, planning to offer 53.407 million H shares globally. 3. CSPC Pharmaceutical Group (01093.HK): Smegglutide long-acting injection (SYH 9017) has received clinical trial approval in the United States. 4. Zhaoke Eye Hospital (06622.HK): The board of directors has approved a twelve-month share repurchase program with a total repurchase amount not exceeding HK$100 million. 5. Yuexiu Property (00123.HK): In May, the company achieved contracted sales (including contracted sales from joint ventures and associates) of approximately RMB11.303 billion, representing a year-on-year increase of approximately 18.0%, and contracted sales area of approximately 325,200 square meters, representing a year-on-year increase of approximately 33.0%. 6. Tencent Holdings (00700.HK): On June 8, Tencent repurchased 1.116 million shares on the Hong Kong Stock Exchange for approximately HKD 500 million. 7. Rongchang Biotechnology (09995.HK): The National Medical Products Administration conditionally approved the marketing application of Telitacicept Injection (RC18) for a new indication in the treatment of IgA nephropathy.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.